Apollo Medical Holdings, Inc.AMEHNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +187.48% | +75.73% | -100.00% | +236.50% | -5.03% |
| Gross Profit Growth | -341.73% | -100.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | -188.25% | -3.40% | -100.00% | -82.09% | +0.00% |
| Operating Income Growth | -97.79% | +0.00% | -100.00% | +39.13% | +2026.59% |
| Net Income Growth | -136.32% | -45.84% | -50.85% | -93.31% | +0.00% |
| EPS Growth | -125.53% | -46.15% | -50.00% | -97.06% | +0.00% |
| EPS Diluted Growth | -127.66% | -46.15% | -50.00% | -96.97% | +0.00% |
| Weighted Average Shares Growth | +2.10% | +0.00% | +0.00% | +0.00% | +3.59% |
| Weighted Average Shares Diluted Growth | +1.28% | +0.00% | +0.00% | +0.00% | +4.22% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -78.77% | -13.85% | +0.00% | -70.70% | -188.23% |
| Free Cash Flow Growth | +47.89% | +35.81% | +0.00% | -76.63% | -117.23% |
| Receivables Growth | -37.82% | -40.59% | -91.29% | +544.45% | +312.93% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -12.68% | -6.97% | -29.84% | +100.75% | +136.73% |
| Book Value per Share Growth | +17.58% | -91.09% | +35.46% | -8.11% | +5.55% |
| Debt Growth | -85.03% | -85.22% | -93.82% | +232.14% | +147.32% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +170.19% | +15.67% | -100.00% | +199.21% | -24.18% |